🔎 Trials Near Me

Почетна › Прекумерна телесна тежина › Тексас › Houston

Клинички испитувања за Прекумерна телесна тежина во Houston, TX

33 студии за Прекумерна телесна тежина бараат учесници на локации во и околу Houston (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Се регрутираФаза 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · на 7 милји
Возраст од 18 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Се регрутираФаза 3
  • PlanIt Research, PLLC, Houston
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Се регрутираФаза 3
  • DM Clinical, Houston
Возраст од 8 до 18 · Сите полови · Ажурирано 30.9.2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Се регрутираФаза 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Се регрутираФаза 3
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Се регрутираФаза 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Се регрутираФаза 3
  • Research Site, Houston
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Се регрутираФаза 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • и уште 1
Возраст од 6 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Се регрутираФаза 3
  • Juno Research, Houston
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Се регрутираФаза 3
  • Juno Research, Houston
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Се регрутираФаза 3
  • Research Site, Houston
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Се регрутираФаза 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • и уште 2
Возраст од 45 до 99 · Сите полови · Ажурирано 22.9.2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Се регрутираФаза 3
  • The University of Texas Health Science Center at Houston, Bellaire · на 7 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Се регрутираФаза 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · на 7 милји
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Се регрутираФаза 2
  • PlanIt Research, PLLC, Houston
Возраст од 18 до 75 · Сите полови · Ажурирано 22.9.2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Се регрутираФаза 2Добредојдени се здрави волонтери
  • The University of Texas Health Science Center at Houston, Houston
Возраст од 18 до 75 · Сите полови · Ажурирано 21.9.2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Се регрутираФаза 3
  • AURORA-2 Clinical Site, Houston
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Се регрутираФаза 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Се регрутираФаза 2
  • Juno Research, Houston
Возраст од 18 до 75 · Сите полови · Ажурирано 14.9.2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Се регрутираФаза 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · на 7 милји
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351045

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Се регрутираФаза 3
  • Houston Pulm Med Res Network, Houston
Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Се регрутираФаза 3Добредојдени се здрави волонтери
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Возраст од 18 до 79 · Сите полови · Ажурирано 11.9.2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Се регрутираФаза 3
  • Houston Pulm Med Res Network, Houston
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Се регрутираФаза 2
  • PlanIt Research, PLLC, Houston
Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Се регрутираФаза 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Се регрутираФаза 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · на 7 милји
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Се регрутираФаза 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · на 7 милји
Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Се регрутираФаза 3
  • Kailera Clinical Site, Bellaire · на 7 милји
Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Се регрутираФаза 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · на 7 милји
Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Се регрутираФаза 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Возраст од 18 до 99 · Сите полови · Ажурирано 27.8.2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Се регрутираФаза 3
  • Research Site, Houston
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Се регрутираФаза 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Возраст од 18 до 79 · Сите полови · Ажурирано 10.8.2026 · NCT07654361

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Се регрутираФаза 2
  • Baylor College of Medicine, Houston
Возраст 18 и постари · Сите полови · Ажурирано 16.1.2026 · NCT06273072

Испитувања за Прекумерна телесна тежина во други градови

Други студии во Houston

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.